We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-21.98%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
$0
Cap. Flow
-$63.6K
Cap. Flow %
-0%
Top 10 Hldgs %
13.08%
Holding
3,173
New
–
Increased
3
Reduced
4
Closed
–

Top Buys

Rank Stock Value
1
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
+$51.9K
2
OVV icon
Ovintiv
OVV
+$14.7K
3
VANI icon
Vivani Medical
VANI
+$119

Top Sells

Rank Stock Value
1
BIP icon
Brookfield Infrastructure Partners
BIP
+$78.8K
2
TU icon
Telus
TU
+$37K
3
ODFL icon
Old Dominion Freight Line
ODFL
+$14.5K
4
BBBY
Bed Bath & Beyond
BBBY
+$11

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTG icon
2351
MGIC Investment
MTG
$6.16B
$2K ﹤0.01%
180
– –
ACH
2352
Accendra Health
ACH
$237M
$2K ﹤0.01%
574
– –
PULM icon
2353
Pulmatrix
PULM
$6.35M
$2K ﹤0.01%
130
– –
RDNT icon
2354
RadNet
RDNT
$5.02B
$2K ﹤0.01%
146
– –
RES icon
2355
RPC Inc
RES
$1.25B
$2K ﹤0.01%
439
– –
RRGB icon
2356
Red Robin
RRGB
$145M
$2K ﹤0.01%
88
– –
RRX icon
2357
Regal Rexnord
RRX
$13.7B
$2K ﹤0.01%
34
– –
SRDX
2358
DELISTED
Surmodics
SRDX
$2K ﹤0.01%
53
– –
TEX icon
2359
Terex
TEX
$7.21B
$2K ﹤0.01%
94
– –
TG icon
2360
Tredegar Corp
TG
$265M
$2K ﹤0.01%
110
– –
TRS icon
2361
TriMas Corp
TRS
$1.43B
$2K ﹤0.01%
79
– –
UNFI icon
2362
United Natural Foods
UNFI
$3.08B
$2K ﹤0.01%
246
– –
UTHR icon
2363
United Therapeutics
UTHR
$25.8B
$2K ﹤0.01%
24
– –
VAW icon
2364
Vanguard Materials ETF
VAW
$2.95B
$2K ﹤0.01%
20
– –
VTLE
2365
DELISTED
Vital Energy
VTLE
$2K ﹤0.01%
47
– –
WASH icon
2366
Washington Trust Bancorp
WASH
$743M
$2K ﹤0.01%
47
– –
WRLD icon
2367
World Acceptance Corp
WRLD
$837M
$2K ﹤0.01%
30
– –
WSR
2368
DELISTED
Whitestone REIT
WSR
$2K ﹤0.01%
203
– –
CHUY
2369
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$2K ﹤0.01%
115
– –
TARO
2370
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$2K ﹤0.01%
24
– –
ROCC
2371
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$2K ﹤0.01%
81
– –
AIMC
2372
DELISTED
Altra Industrial Motion Corp
AIMC
$2K ﹤0.01%
67
– –
ZNH
2373
DELISTED
China Southern Airlines Company Limited
ZNH
$2K ﹤0.01%
66
– –
VIVO
2374
DELISTED
Meridian Bioscience Inc
VIVO
$2K ﹤0.01%
296
– –
SAFM
2375
DELISTED
Sanderson Farms Inc
SAFM
$2K ﹤0.01%
12
– –
93 94
95
96 97

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q1 2020 Portfolio in Review

As of Q1 2020, Glenmede Trust held 3,173 positions worth $21.9B, unchanged from the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Trading was light in Q1 2020: portfolio turnover was 0%. Glenmede Trust opened no new positions and made no exits, leaving the 3,173-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, unchanged from a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust added most to Interpace Biosciences, Inc. Common Stock in Q1 2020, an estimated $51.9K increase.
  • Glenmede Trust's biggest Q1 2020 reduction was Brookfield Infrastructure Partners, cutting an estimated $78.8K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q1 2020.
  • Glenmede Trust opened 0 new positions and closed 0 in Q1 2020.
  • Glenmede Trust's portfolio value was unchanged quarter-over-quarter at $21.9B.

Based on Glenmede Trust's 13F filing for Q1 2020, filed 20 May 2020.